Medical School · Year 3 · Internal Medicine · includes a quiz and discussion video

Seminar 03: Approach to Edema

Year 3: Internal Medicine Clerkship

Learning Objectives

By the end of this seminar, students will be able to:

1. Explain the pathophysiology of edema formation
2. Differentiate localized from generalized edema
3. Describe the major causes of peripheral edema
4. Develop a systematic diagnostic approach to edema
5. Apply appropriate management strategies based on etiology
6. Recognize life-threatening causes of edema

Seminar Outline

I. Pathophysiology of Edema

Understanding edema formation requires knowledge of the Starling forces that govern fluid movement across capillary membranes. Capillary hydrostatic pressure serves as the primary force pushing fluid out of the intravascular space into the interstitium, while interstitial hydrostatic pressure provides a counteracting force that pushes fluid back toward the capillary. Plasma oncotic pressure, generated predominantly by albumin, acts to pull fluid into the vascular compartment by creating an osmotic gradient. Interstitial oncotic pressure, though typically low, can pull fluid out of the capillary when elevated in pathologic states such as lymphatic obstruction.

The mechanisms leading to edema formation can be broadly categorized by which Starling force has been disrupted. Increased capillary hydrostatic pressure occurs in conditions like congestive heart failure and venous obstruction, where elevated venous pressures are transmitted retrograde to the capillary bed. Decreased plasma oncotic pressure results from hypoalbuminemia seen in nephrotic syndrome, liver failure, and severe malnutrition, reducing the force that normally retains fluid intravascularly. Increased capillary permeability allows protein-rich fluid to leak into the interstitium, occurring in inflammatory states such as burns, sepsis, and allergic reactions. Lymphatic obstruction prevents normal interstitial fluid drainage, leading to protein-rich edema in conditions like malignancy and post-surgical lymphedema.

Edema can be characterized by its physical properties and response to pressure. Pitting edema leaves an indentation when pressure is applied and released, indicating fluid accumulation in the interstitium that can be temporarily displaced. Non-pitting edema does not leave an indentation and is characteristic of lymphedema and myxedema, where protein-rich fluid or mucopolysaccharide accumulation creates a firmer tissue consistency. Dependent edema distributes according to gravity, appearing in the lower extremities in ambulatory patients and the sacral area in bedridden individuals. Generalized edema, termed anasarca, represents widespread fluid accumulation typically indicating a systemic cause.

Distribution patterns provide important diagnostic clues regarding edema etiology. Bilateral lower extremity edema suggests systemic causes including heart failure, liver disease, and kidney disease, as these conditions affect overall fluid balance. Unilateral leg edema indicates localized pathology such as deep vein thrombosis, lymphedema, or venous insufficiency affecting that specific limb. Periorbital edema is characteristic of nephrotic syndrome, allergic reactions, and hypothyroidism, reflecting the loose connective tissue around the eyes. Ascites, or fluid accumulation in the peritoneal cavity, most commonly results from liver disease but can also occur with heart failure and malignancy.

<image>Panel A: Starling forces diagram showing the four pressures (capillary hydrostatic, interstitial hydrostatic, plasma oncotic, and interstitial oncotic) with arrows indicating direction of fluid movement across a capillary wall. Panel B: Clinical photographs comparing pitting versus non-pitting edema with finger pressure demonstration showing indentation depth and recovery time. Panel C: Body diagram showing distribution patterns of edema in different conditions - bilateral leg edema, unilateral leg edema, periorbital edema, and sacral edema with associated causes labeled. Panel D: Cross-sectional illustration of tissue layers showing normal interstitium versus edematous interstitium with expanded extracellular fluid compartment.</image>

II. History Taking

A thorough history begins with characterizing the edema itself through specific questions about its location, timing, and associated features. Patients should describe whether the swelling affects their legs, face, hands, or abdomen, as the distribution provides crucial diagnostic information. The onset may be sudden, as seen in DVT or allergic reactions, or gradual and progressive, as typical of heart failure or cirrhosis. Duration helps distinguish acute processes from chronic conditions that have developed over months to years. Timing throughout the day, such as morning periorbital swelling versus evening leg swelling, and positional changes with elevation provide additional diagnostic clues.

Associated symptoms help narrow the differential diagnosis significantly based on which organ systems are involved. Dyspnea and orthopnea suggest cardiac involvement, as pulmonary congestion accompanies right-sided failure that causes peripheral edema. Abdominal distension may indicate ascites from liver disease or heart failure, often accompanied by early satiety and increasing abdominal girth. Decreased urine output points toward kidney disease with impaired sodium and water excretion. Weight gain should be quantified as a marker of fluid retention, with patients often reporting several pounds of gain over days to weeks. Fatigue may indicate underlying anemia, hypothyroidism, or advanced heart failure with decreased cardiac output.

Medical history review identifies conditions predisposing to edema formation through known pathophysiologic mechanisms. Prior heart disease increases the likelihood that new edema represents heart failure exacerbation requiring immediate attention. Liver disease history, including alcohol use and viral hepatitis, raises suspicion for cirrhosis with portal hypertension. Kidney disease, whether chronic kidney disease or prior episodes of nephrotic syndrome, directly causes sodium retention and edema. Cancer history is relevant for both direct lymphatic obstruction and paraneoplastic syndromes. Thyroid disease should be assessed, as hypothyroidism causes non-pitting myxedema through mucopolysaccharide deposition. Recent surgery increases risk for venous stasis and deep vein thrombosis in the affected extremity.

Medication review is essential as numerous drug classes cause peripheral edema through various mechanisms. Calcium channel blockers, particularly dihydropyridines like amlodipine, cause arteriolar dilation that increases capillary hydrostatic pressure and produces ankle swelling in up to 10% of patients. NSAIDs promote sodium retention through prostaglandin inhibition in the kidney, exacerbating edema from any underlying cause. Thiazolidinediones used for diabetes increase fluid retention and can precipitate heart failure in susceptible individuals. Systemic corticosteroids cause sodium retention and can produce significant weight gain and peripheral swelling. Estrogens and oral contraceptives promote fluid retention through hormonal effects on the renin-angiotensin system. Gabapentin and pregabalin frequently cause peripheral edema through unclear mechanisms, affecting up to 7% of patients taking these medications.

<image>Panel A: Flow diagram for edema history-taking showing the systematic approach from characterization (location, onset, timing) to associated symptoms to medical history to medication review. Panel B: Illustration of medication bottles with common edema-causing drugs labeled (CCBs, NSAIDs, TZDs, steroids, estrogens, gabapentinoids) with their mechanisms. Panel C: Timeline graphic showing acute versus chronic edema with typical causes at each timepoint. Panel D: Checklist format of red flag symptoms requiring urgent evaluation including sudden unilateral swelling, dyspnea, chest pain, and decreased urine output.</image>

III. Physical Examination

Physical examination of edema requires systematic assessment including location, character, and severity using standardized techniques. Examination should begin with inspection to identify the anatomic distribution of swelling, noting whether it involves the lower extremities, sacral area, periorbital region, or is generalized. The pitting test is performed by pressing firmly with the thumb over a bony prominence such as the tibia or medial malleolus for approximately ten seconds and observing for indentation. The extent of edema should be documented by noting how high up the leg the swelling extends, whether to the ankle, mid-calf, knee, or thigh. Skin changes including color, temperature, ulceration, and hair loss provide clues to chronicity and etiology, with hemosiderin staining and lipodermatosclerosis indicating chronic venous insufficiency.

Pitting edema grading provides a standardized method for documenting severity and following response to treatment. Grade 1+ edema produces a 2-millimeter indentation that recovers immediately, representing mild fluid accumulation. Grade 2+ edema creates a 4-millimeter indentation with recovery time under 15 seconds, indicating moderate swelling. Grade 3+ edema shows a 6-millimeter indentation with recovery taking 15 to 30 seconds, representing significant fluid overload. Grade 4+ edema produces an 8-millimeter or greater indentation with recovery time exceeding 30 seconds, indicating severe edema often associated with advanced heart failure or nephrotic syndrome. The grading scale helps track progression or improvement with therapy.

Cardiovascular examination provides critical information when cardiac causes of edema are suspected. Jugular venous distension indicates elevated right atrial pressure and is assessed with the patient reclined at 45 degrees, with JVD greater than 3 centimeters above the sternal angle being abnormal. An S3 gallop on auscultation suggests left ventricular systolic dysfunction and is heard best at the apex with the bell of the stethoscope. Hepatomegaly with tenderness indicates hepatic congestion from right heart failure, and the liver span should be percussed. The hepatojugular reflux test, performed by sustained abdominal pressure while observing the JVP, is positive when the JVP rises and remains elevated, supporting the diagnosis of heart failure. Peripheral pulses should be assessed for arterial insufficiency that may coexist with venous disease.

Additional examination findings may reveal the underlying cause of edema or suggest specific diagnoses. Ascites is detected through percussion for shifting dullness and fluid wave in patients with abdominal distension, present when significant intraperitoneal fluid has accumulated. Stigmata of chronic liver disease including spider angiomata on the chest, palmar erythema, gynecomastia, and caput medusae suggest cirrhosis as the cause. Thyroid examination may reveal an enlarged gland in hypothyroidism or a nodule requiring further evaluation. Lymphadenopathy, particularly in the inguinal or supraclavicular regions, raises concern for malignancy causing lymphatic obstruction. Skin examination may show the brawny, non-pitting quality of lymphedema or the pretibial myxedema of Graves disease.

<image>Panel A: Photograph sequence demonstrating the pitting edema test technique with timing of thumb pressure and depth measurement. Panel B: Four clinical photographs showing 1+, 2+, 3+, and 4+ pitting edema with corresponding indentation depths labeled. Panel C: Illustration of cardiovascular examination findings in heart failure including JVD measurement technique, S3 gallop location, hepatomegaly assessment, and hepatojugular reflux test. Panel D: Photograph collection of associated physical findings including spider angiomata, palmar erythema, caput medusae, and skin changes of chronic venous insufficiency.</image>

IV. Cardiac Causes

Heart failure is the most common cardiac cause of peripheral edema, resulting from complex hemodynamic and neurohormonal derangements. The fundamental mechanism involves decreased cardiac output leading to renal hypoperfusion, which activates the renin-angiotensin-aldosterone system and promotes sodium and water retention. Right-sided heart failure manifests with peripheral edema, elevated jugular venous pressure, and hepatomegaly due to venous congestion proximal to the failing right ventricle. Left-sided heart failure primarily causes pulmonary edema and dyspnea, though chronic left heart failure eventually leads to right ventricular dysfunction and peripheral edema. B-type natriuretic peptide levels are elevated in heart failure and help distinguish cardiac from non-cardiac causes of edema. Treatment centers on diuretics for volume management along with guideline-directed medical therapy including ACE inhibitors, beta-blockers, and mineralocorticoid receptor antagonists.

The symptom complex of heart failure provides diagnostic clues that help identify cardiac edema. Orthopnea, the sensation of dyspnea when lying flat, occurs because venous return increases in the supine position, overwhelming the failing heart's ability to handle the volume. Paroxysmal nocturnal dyspnea develops when the patient awakens suddenly with severe shortness of breath, typically 1-2 hours after falling asleep, as fluid redistributes from the extremities to the lungs. Exertional dyspnea reflects decreased cardiac reserve and inability to augment cardiac output during physical activity. Fatigue develops from inadequate tissue perfusion and is often an early symptom that patients attribute to aging or deconditioning. Weight gain from fluid retention may be rapid, with patients gaining several pounds over just a few days during acute decompensation.

Constrictive pericarditis represents an important cardiac cause of edema that mimics heart failure but requires different treatment. The underlying mechanism involves thickening and fibrosis of the pericardium that restricts ventricular filling during diastole. Clinical presentation includes edema, ascites that may be disproportionate to peripheral edema, and elevated jugular venous pressure. Kussmaul sign, a paradoxical rise in JVP with inspiration, is classic for constrictive pericarditis and results from the inability of the right ventricle to accommodate increased venous return. Diagnosis requires imaging with CT or MRI to demonstrate pericardial thickening, along with cardiac catheterization showing characteristic hemodynamic findings. Treatment is surgical pericardiectomy when medical management fails.

Pulmonary hypertension leads to right ventricular failure and peripheral edema through elevated pulmonary vascular resistance. The mechanism involves chronic pressure overload of the right ventricle, which initially hypertrophies but eventually fails, leading to elevated right-sided filling pressures and systemic venous congestion. Clinical presentation includes progressive dyspnea on exertion, edema, and signs of right heart failure including JVD and hepatomegaly. Echocardiography provides the initial assessment, showing elevated estimated pulmonary artery pressures and right ventricular dysfunction. Right heart catheterization is required for definitive diagnosis and classification of pulmonary hypertension by etiology. Treatment depends on the underlying cause, ranging from optimization of left heart disease to specific pulmonary vasodilator therapy for pulmonary arterial hypertension.

<image>Panel A: Heart failure pathophysiology diagram showing the cycle from decreased cardiac output to RAAS activation to sodium retention to edema formation, with BNP elevation indicated. Panel B: Clinical illustration comparing right-sided versus left-sided heart failure findings with peripheral edema, JVD, and hepatomegaly on right and pulmonary edema, orthopnea, and PND on left. Panel C: Imaging comparison of constrictive pericarditis showing CT with thickened pericardium, echocardiogram with septal bounce, and catheterization pressure tracings. Panel D: Algorithm for cardiac edema evaluation starting with history and exam, proceeding to BNP and echocardiogram, with decision points for right versus left heart failure and need for additional testing.</image>

V. Hepatic Causes

Cirrhosis produces edema and ascites through multiple interacting mechanisms that disrupt normal fluid homeostasis. Portal hypertension develops as fibrotic liver tissue increases resistance to portal venous flow, transmitting elevated pressures to the splanchnic circulation. This portal hypertension causes splanchnic vasodilation, which paradoxically decreases effective circulating volume despite total body fluid excess, triggering compensatory activation of the renin-angiotensin-aldosterone system and renal sodium retention. Hypoalbuminemia from impaired hepatic synthetic function decreases plasma oncotic pressure, favoring fluid movement into the interstitium and peritoneal cavity. The combination of elevated portal pressure and decreased oncotic pressure produces the classic ascites of cirrhosis, while peripheral edema typically accompanies advanced disease.

Assessment of ascites involves both physical examination and diagnostic paracentesis to determine etiology. Physical examination maneuvers include percussion for flank dullness, which is present when ascitic fluid accumulates in the dependent portions of the abdomen. Shifting dullness, the change in location of dullness when the patient moves from supine to lateral decubitus position, indicates freely mobile ascitic fluid. The fluid wave test, performed by having an assistant press along the midline while tapping one flank and feeling for transmitted impulse on the opposite flank, is positive with larger volumes of ascites. Diagnostic paracentesis should be performed on all patients with new ascites to determine the cause and rule out infection.

The serum-ascites albumin gradient (SAAG) provides the key laboratory parameter for classifying ascites etiology. Calculation involves subtracting the ascites albumin concentration from the serum albumin concentration obtained on the same day. A SAAG of 1.1 g/dL or greater indicates portal hypertension is present, seen in cirrhosis, heart failure, and Budd-Chiari syndrome. A SAAG below 1.1 g/dL indicates ascites from causes other than portal hypertension, including peritoneal carcinomatosis, tuberculous peritonitis, and nephrotic syndrome. Additional ascites testing should include total protein, cell count with differential to evaluate for spontaneous bacterial peritonitis, and cultures when infection is suspected. The SAAG has greater than 95% accuracy for distinguishing portal hypertensive from non-portal hypertensive ascites.

Hepatorenal syndrome represents the most serious complication of cirrhosis-related fluid derangements, characterized by functional renal failure. Type 1 hepatorenal syndrome involves rapid deterioration of kidney function with serum creatinine doubling within two weeks, carrying a very poor prognosis with median survival of only two weeks without treatment. Type 2 hepatorenal syndrome shows more gradual decline in renal function and is typically associated with refractory ascites. The mechanism involves extreme splanchnic vasodilation causing severe renal vasoconstriction as a compensatory mechanism to maintain blood pressure. Diagnosis requires exclusion of other causes of renal failure and demonstration that kidney function does not improve with volume expansion. Treatment includes vasoconstrictors such as midodrine and octreotide combined with albumin infusion, with liver transplantation being the only definitive cure.

<image>Panel A: Pathophysiology diagram of cirrhotic ascites showing portal hypertension, splanchnic vasodilation, RAAS activation, and sodium retention cycle with arrows indicating relationships. Panel B: Clinical photograph of abdominal distension with ascites and illustration of examination techniques for flank dullness, shifting dullness, and fluid wave. Panel C: SAAG interpretation flowchart with high SAAG (portal hypertension) causes on one branch and low SAAG (other causes) on opposite branch. Panel D: Hepatorenal syndrome algorithm showing diagnostic criteria, type 1 versus type 2 classification, and treatment approach with vasoconstrictors and albumin.</image>

VI. Renal Causes

Nephrotic syndrome represents a major renal cause of edema characterized by heavy proteinuria and its metabolic consequences. The diagnostic criteria require proteinuria exceeding 3.5 grams per day, accompanied by hypoalbuminemia below 3 g/dL resulting from urinary protein losses. Edema in nephrotic syndrome characteristically involves the periorbital area, which is often noticed first by patients upon awakening, and becomes generalized as the syndrome progresses. Hyperlipidemia develops as the liver increases lipoprotein synthesis in response to decreased oncotic pressure, producing elevated LDL and total cholesterol. The mechanism of edema involves both decreased plasma oncotic pressure from hypoalbuminemia and primary renal sodium retention that occurs independently of volume status.

The causes of nephrotic syndrome can be divided into primary glomerular diseases and secondary causes affecting the kidney. Primary causes include minimal change disease, which is most common in children and responds to corticosteroids, and focal segmental glomerulosclerosis (FSGS), which often progresses to chronic kidney disease. Membranous nephropathy is a common primary cause in adults and may be associated with malignancy requiring age-appropriate screening. Secondary causes include diabetic nephropathy, the most common cause of nephrotic syndrome in adults overall, along with systemic lupus erythematosus, amyloidosis, and viral infections. Evaluation requires urinalysis showing heavy proteinuria, quantification with 24-hour urine or spot urine protein-to-creatinine ratio, and often kidney biopsy to determine the specific diagnosis and guide treatment.

Nephritic syndrome differs from nephrotic syndrome in its clinical presentation and implications. Edema is typically less prominent in nephritic syndrome compared to nephrotic syndrome, though fluid retention still occurs. The hallmark of nephritic syndrome is active urinary sediment with dysmorphic red blood cells and red cell casts indicating glomerular inflammation. Hypertension is common and results from sodium retention and activation of the renin-angiotensin system. The mechanism involves glomerular inflammation that reduces the glomerular filtration rate and impairs sodium excretion. Examples of nephritic syndrome include post-streptococcal glomerulonephritis, IgA nephropathy, and ANCA-associated vasculitis, each requiring specific evaluation and treatment.

Chronic kidney disease causes edema through progressive impairment of the kidney's ability to excrete sodium and water. The mechanism is straightforward: as nephron mass decreases, the remaining nephrons cannot adequately handle the filtered sodium load, leading to positive sodium balance and volume expansion. Edema in CKD is bilateral and dependent, typically involving the lower extremities in ambulatory patients. Other features of advanced CKD accompany the edema, including anemia from decreased erythropoietin production, metabolic acidosis from impaired acid excretion, and bone disease from disordered calcium and phosphorus metabolism. Treatment of CKD-related edema involves salt restriction as the foundation, loop diuretics to enhance sodium excretion, and ultimately dialysis when conservative measures fail.

<image>Panel A: Nephrotic syndrome pathophysiology showing glomerular protein loss leading to hypoalbuminemia, decreased oncotic pressure, and edema formation, with compensatory hepatic lipoprotein synthesis. Panel B: Comparison table in visual format showing clinical and laboratory differences between nephrotic and nephritic syndromes. Panel C: Kidney biopsy photomicrographs showing minimal change disease, FSGS, membranous nephropathy, and diabetic nephropathy with characteristic findings labeled. Panel D: CKD staging diagram with associated edema severity and treatment approach at each stage from dietary salt restriction through diuretics to dialysis.</image>

VII. Venous Causes

Deep vein thrombosis is a common and potentially life-threatening cause of unilateral leg edema requiring prompt diagnosis and treatment. The clinical presentation typically includes unilateral leg swelling that develops over hours to days, accompanied by pain, warmth, and sometimes visible erythema over the affected extremity. Risk factors follow Virchow's triad of stasis, endothelial injury, and hypercoagulability, including recent immobilization, surgery, malignancy, pregnancy, and use of estrogen-containing medications. The most serious complication is pulmonary embolism, which occurs when clot dislodges and travels to the pulmonary vasculature, potentially causing hemodynamic compromise or death. Diagnosis involves clinical assessment using the Wells score for DVT, D-dimer testing in low-probability cases, and compression ultrasonography to visualize the thrombus. Treatment consists of anticoagulation, typically with direct oral anticoagulants as first-line therapy, to prevent clot propagation and recurrence.

The Wells score provides a validated clinical prediction rule to estimate the pretest probability of DVT. Points are assigned for active cancer, paralysis or recent lower extremity immobilization, being bedridden for more than three days or surgery within twelve weeks, localized tenderness along the deep venous system, entire leg swelling, calf swelling more than three centimeters greater than the asymptomatic leg, pitting edema in the symptomatic leg, and collateral superficial veins. Two points are subtracted if an alternative diagnosis is as likely as or more likely than DVT. A score of three or greater indicates high probability with approximately 50% prevalence of DVT, while a score of zero or less indicates low probability where D-dimer testing can effectively rule out the diagnosis. The score guides the diagnostic approach, with high-probability patients proceeding directly to ultrasonography.

Chronic venous insufficiency develops from venous valve incompetence and causes chronic bilateral leg edema with characteristic skin changes. The underlying mechanism involves failure of the valves that normally prevent retrograde flow in leg veins, leading to venous hypertension and chronic capillary damage. Clinical presentation includes bilateral leg swelling that worsens with prolonged standing and improves with elevation and overnight rest. Skin changes progress over time, beginning with hemosiderin staining from red blood cell extravasation, advancing to lipodermatosclerosis (indurated, woody texture of the skin), and ultimately venous stasis ulcers that typically occur at the medial malleolus. Treatment emphasizes compression therapy with graduated compression stockings, leg elevation, and wound care for ulcers when present.

May-Thurner syndrome represents an anatomic cause of venous obstruction that should be considered in specific clinical scenarios. The underlying anatomy involves compression of the left common iliac vein between the right common iliac artery anteriorly and the lumbar spine posteriorly. This compression predisposes to left leg deep vein thrombosis, particularly in young women who may have no other risk factors for DVT. Clinical presentation is typically an unprovoked left leg DVT in a patient without traditional risk factors. Diagnosis requires imaging beyond routine ultrasonography, including CT venography or intravascular ultrasound to demonstrate the anatomic compression. Treatment involves anticoagulation for the acute DVT plus consideration of endovascular stenting to address the underlying compression and prevent recurrence.

<image>Panel A: Clinical photograph of unilateral leg edema from DVT with measurement technique comparing leg circumferences and annotation of typical clinical findings. Panel B: Wells score calculator in visual format showing point assignments for each criterion with pretest probability categories. Panel C: Progression of chronic venous insufficiency skin changes shown in four photographs from early hemosiderin staining through lipodermatosclerosis to venous ulcer. Panel D: Anatomic illustration of May-Thurner syndrome showing left iliac vein compression between right iliac artery and spine, with corresponding CT venography and treatment approach.</image>

VIII. Lymphatic Causes

Primary lymphedema results from congenital abnormalities of lymphatic development and presents at different ages depending on the specific type. Congenital lymphedema (Milroy disease) is present at birth and results from lymphatic hypoplasia, affecting the lower extremities more commonly than upper extremities. Lymphedema praecox develops around puberty through age 35, predominantly affects females, and is the most common form of primary lymphedema. Lymphedema tarda appears after age 35 and may represent delayed manifestation of underlying lymphatic insufficiency. The underlying mechanism in all forms involves inadequate lymphatic drainage capacity, whether from absent, hypoplastic, or dysfunctional lymphatic vessels, leading to accumulation of protein-rich fluid in the interstitium.

Secondary lymphedema is far more common than primary forms and results from acquired damage to the lymphatic system. Malignancy causes lymphedema through direct lymphatic invasion, lymph node involvement, or as a consequence of cancer treatment. Surgical lymph node dissection, particularly axillary dissection for breast cancer, is a leading cause of upper extremity lymphedema in developed countries. Radiation therapy damages lymphatic vessels and nodes, often causing lymphedema that develops months to years after treatment completion. Infection is the most common cause of secondary lymphedema worldwide, particularly filariasis caused by parasitic worms in endemic tropical regions. Recurrent bacterial cellulitis can progressively damage lymphatics and worsen pre-existing lymphedema. Trauma and surgical procedures can disrupt lymphatic channels leading to localized or regional lymphedema.

The clinical features of lymphedema distinguish it from other causes of extremity swelling. Early lymphedema produces pitting edema that may be indistinguishable from other causes, but chronic lymphedema becomes non-pitting as protein accumulation stimulates fibrosis. The Stemmer sign, inability to pinch and lift a fold of skin at the base of the second toe, is highly specific for lymphedema and helps differentiate it from venous edema. Skin changes progress over time, including thickening, hyperkeratosis, and development of papillomatous projections in advanced cases. Unlike venous edema, lymphedema typically involves the dorsum of the foot and toes (the "squared-off" toe appearance), whereas venous edema tends to spare these areas. The swelling does not improve as dramatically with overnight elevation compared to venous edema because of the protein-rich nature of lymphatic fluid.

Management of lymphedema focuses on reducing swelling and preventing complications, as the underlying lymphatic abnormality usually cannot be corrected. Complete decongestive therapy (CDT) is the cornerstone of treatment, combining manual lymphatic drainage, compression bandaging, exercises, and meticulous skin care. Compression is maintained long-term through properly fitted gradient compression garments that must be replaced regularly as they lose elasticity. Manual lymphatic drainage is a specialized massage technique that redirects lymphatic flow through functioning lymphatic pathways. Exercise promotes lymphatic flow through muscle pumping action and should be performed while wearing compression garments. Skin care is essential to prevent bacterial and fungal infections that can trigger cellulitis episodes and worsen lymphedema. Surgical options including lymphovenous anastomosis and vascularized lymph node transfer are emerging for selected patients.

<image>Panel A: Classification diagram of primary lymphedema showing Milroy disease (congenital), praecox, and tarda with typical age of onset, gender predominance, and affected regions. Panel B: Clinical photographs comparing secondary lymphedema causes including post-mastectomy arm lymphedema, post-radiation changes, and filarial elephantiasis. Panel C: Examination technique photographs demonstrating the Stemmer sign with positive and negative findings, and clinical photographs showing characteristic lymphedema features (squared toes, skin thickening). Panel D: Complete decongestive therapy components illustrated including manual lymphatic drainage technique, multilayer compression bandaging, therapeutic exercises, and skin care routine.</image>

IX. Diagnostic Workup

Initial laboratory testing provides essential information for determining the underlying cause of edema. A complete blood count may reveal anemia contributing to high-output heart failure, polycythemia suggesting chronic hypoxia, or evidence of infection. The basic metabolic panel assesses renal function through creatinine and BUN, identifies electrolyte abnormalities that may complicate treatment, and glucose levels screen for diabetes as an underlying condition. Liver function tests including albumin, bilirubin, and transaminases evaluate for liver disease as a cause of hypoalbuminemia and ascites. Urinalysis identifies proteinuria that suggests nephrotic syndrome when heavy or glomerulonephritis when accompanied by hematuria. Thyroid-stimulating hormone (TSH) should be checked to evaluate for hypothyroidism, which can cause myxedema.

Cardiac workup is essential when heart failure is suspected based on history, examination, or distribution of edema. B-type natriuretic peptide (BNP) or N-terminal pro-BNP (NT-proBNP) helps differentiate cardiac from non-cardiac causes of dyspnea and edema, with levels below 100 pg/mL (BNP) making heart failure very unlikely. Echocardiography provides comprehensive assessment of cardiac structure and function, including left ventricular ejection fraction, diastolic function, right ventricular function, and valve abnormalities. Chest radiography may show cardiomegaly, pulmonary vascular congestion, pleural effusions, and other findings supporting heart failure diagnosis. An electrocardiogram may reveal arrhythmias such as atrial fibrillation, evidence of prior myocardial infarction, or conduction abnormalities.

Venous workup focuses on evaluating for deep vein thrombosis and chronic venous insufficiency. D-dimer testing is useful in patients with low pretest probability of DVT, as a negative result effectively excludes the diagnosis without need for imaging. Compression ultrasonography is the diagnostic standard for DVT, demonstrating lack of vein compressibility and visualizing intraluminal thrombus. CT venography provides detailed imaging of pelvic and iliofemoral veins when ultrasonography is limited or when anatomic abnormalities like May-Thurner syndrome are suspected. For suspected chronic venous insufficiency, venous duplex ultrasonography with assessment of valve function identifies reflux in the superficial, deep, and perforator veins.

Additional specialized testing may be required based on clinical suspicion when initial workup is unrevealing. Twenty-four hour urine protein quantification or spot urine protein-to-creatinine ratio documents the degree of proteinuria in suspected nephrotic syndrome. Serum protein electrophoresis (SPEP) and urine protein electrophoresis (UPEP) screen for paraprotein disorders including multiple myeloma and amyloidosis. CT of the abdomen and pelvis evaluates for malignancy, lymphadenopathy, or intra-abdominal processes causing lymphatic obstruction or ascites. Lymphoscintigraphy is the gold standard for evaluating lymphatic function, using radiolabeled tracer to visualize lymphatic transport and identify sites of obstruction or abnormal drainage.

<image>Panel A: Laboratory testing algorithm showing first-line tests (CBC, BMP, LFTs, urinalysis, TSH) with abnormal results branching to second-line testing based on findings. Panel B: Cardiac workup components including BNP interpretation chart, echocardiogram images showing normal versus reduced ejection fraction, and chest X-ray findings in heart failure. Panel C: Venous workup flowchart incorporating Wells score, D-dimer decision points, and ultrasound findings of acute DVT and chronic venous insufficiency. Panel D: Advanced diagnostic imaging examples including lymphoscintigraphy showing normal versus abnormal lymphatic drainage patterns and CT showing lymphadenopathy causing lymphatic obstruction.</image>

X. Management

General measures form the foundation of edema management regardless of underlying etiology. Sodium restriction to less than 2 grams daily reduces the osmotic drive for water retention and enhances the effectiveness of diuretic therapy. Fluid restriction is primarily indicated for hyponatremic patients, as restricting fluids in normonatremic edema provides minimal benefit and may cause patient discomfort. Leg elevation above heart level for 30 minutes several times daily and while sleeping uses gravity to promote fluid return to the central circulation. Compression stockings help maintain venous and lymphatic return, with graduated compression providing greatest pressure at the ankle that decreases proximally. Daily weight monitoring provides objective tracking of fluid status, with patients instructed to report weight gain exceeding 2-3 pounds in a day or 5 pounds in a week.

Diuretic therapy is central to managing edema from cardiac, hepatic, and renal causes. Loop diuretics such as furosemide are most commonly used, acting on the thick ascending limb of the loop of Henle to inhibit sodium chloride reabsorption and produce brisk diuresis. Thiazide diuretics are less potent but may be added to loop diuretics for synergistic effect when monotherapy is insufficient. Spironolactone, a mineralocorticoid receptor antagonist, is particularly important in cirrhotic ascites because of the prominent role of aldosterone in hepatic sodium retention, and provides mortality benefit in heart failure. The combination of spironolactone 100 mg and furosemide 40 mg maintains potassium balance and is a common starting regimen for cirrhotic ascites. Dosing should be titrated based on response, monitoring electrolytes and renal function, with goal of 1-2 kg weight loss daily in hospitalized patients.

Diuretic resistance develops when standard doses fail to produce adequate diuresis, requiring escalation of therapy. Common causes include dietary non-compliance with excessive sodium intake that overwhelms diuretic effect, poor oral absorption of furosemide (which has variable bioavailability) that can be addressed by switching to IV administration, and reduced delivery of diuretic to the kidney in states of decreased renal blood flow. Strategies to overcome resistance include increasing the loop diuretic dose, adding a thiazide diuretic (metolazone is commonly used) to block compensatory distal sodium reabsorption, continuous IV infusion of loop diuretics to maintain constant drug levels, and combining albumin infusion with furosemide in severely hypoalbuminemic patients (though evidence for this approach is mixed).

Treatment must address the underlying cause of edema rather than relying solely on symptomatic diuretic therapy. Heart failure requires guideline-directed medical therapy including ACE inhibitors or ARNI, beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors, which address the neurohormonal derangements driving fluid retention. Cirrhosis management combines sodium restriction with aldosterone antagonist-based diuretic therapy, large-volume paracentesis with albumin replacement for tense ascites, and evaluation for liver transplantation in appropriate candidates. Nephrotic syndrome treatment targets the underlying glomerular disease with immunosuppression when indicated, along with diuretics and dietary sodium restriction for edema control. Deep vein thrombosis requires anticoagulation to prevent clot propagation and recurrence. Lymphedema management emphasizes complete decongestive therapy with compression as the cornerstone.

<image>Panel A: Lifestyle modification infographic showing salt restriction examples (labeled foods to avoid, daily limit), leg elevation position, compression stocking proper fit, and weight monitoring chart. Panel B: Diuretic mechanism diagram showing site of action for loop diuretics, thiazides, and potassium-sparing diuretics in the nephron with relative potency and synergistic combinations. Panel C: Diuretic resistance algorithm showing common causes with corresponding solutions (non-compliance to salt restriction, poor absorption to IV conversion, etc.). Panel D: Disease-specific treatment approach comparison showing cardiac, hepatic, renal, venous, and lymphatic edema with primary treatments and goals for each.</image>

Summary

• Starling forces govern fluid movement: increased capillary hydrostatic pressure, decreased oncotic pressure, increased capillary permeability, and lymphatic obstruction cause edema
• Bilateral edema suggests systemic causes including heart failure, liver disease, and kidney disease
• Unilateral edema suggests localized pathology such as DVT, venous insufficiency, or lymphedema
• Heart failure edema presents with BNP elevation, orthopnea, jugular venous distension, and S3 gallop
• Cirrhosis produces ascites through portal hypertension and hypoalbuminemia, with SAAG distinguishing portal hypertensive from other causes
• Nephrotic syndrome features proteinuria greater than 3.5 g/day, hypoalbuminemia, and periorbital edema
• DVT presents with unilateral painful swelling; diagnose with Wells score algorithm and ultrasound
• Lymphedema is characterized by non-pitting swelling, positive Stemmer sign, and skin changes
• Medications causing edema include calcium channel blockers, NSAIDs, corticosteroids, and thiazolidinediones
• Treatment includes sodium restriction, diuretics, compression, and addressing the underlying cause

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown